Directory
>
Kori Wallace
Kori Wallace
Resident Physician Pediatrics | AbbVie
Greater Chicago Area United States, United States
Kori Wallace
Summary
Kori Wallace is an accomplished MD PhD with extensive experience in clinical development, particularly in immunology and gastroenterology. Currently serving as the Executive Medical Director and Global Development Lead at AbbVie, Kori has demonstrated a strong ability to lead clinical trials and strategic development for phase 3 assets. With a robust background in research, including a PhD focused on immunologic mechanisms, Kori has contributed significantly to the understanding of inflammatory bowel disease. Kori's career trajectory reflects a commitment to advancing medical science through innovative clinical practices and research. Beyond technical expertise, Kori is recognized for leadership in multidisciplinary teams, fostering collaboration across various departments. Kori's academic foundation from the University of Virginia and Arizona State University complements a practical approach to problem-solving in clinical settings. Passionate about improving patient outcomes, Kori remains at the forefront of emerging medical technologies and treatments.
Kori Wallace
Work Experience
Vice President, Global Head of Immunolgy Clinical Development at
AbbVie
January 2024 - Present
Kori Wallace
Education
University of Virginia, Doctor of Medicine (MD), PhD, Microbiology and Immunology
January 2002 - January 2011
Arizona State University, Bachelor of Science (BS), Biology and Society
January 1998 - January 2002
Frequently Asked Questions about Kori Wallace
What is Kori Wallace email address?
Kori Wallace's primary email address is ************@abbvie.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kori Wallace work for?
Kori Wallace is a Resident Physician Pediatrics at AbbVie.
Where Kori Wallace graduated from?
Kori Wallace holds a degree in MD completed 2011. PhD dissertation completed in 2009 in immunologic mechanisms of sickle cell disease. Focus on T-cell biology and involvement of NKT cells in the pathogens is of vaso-occlusive crisis / ischemia-reperfusion injury. from University of Virginia.
How can I directly contact Kori Wallace?
To contact Kori Wallace directly, you can use the email address ************@abbvie.com. Complete contact information is available upon registration with Muraena.
Who is Kori Wallace?
Kori Wallace is an accomplished MD PhD with extensive experience in clinical development, particularly in immunology and gastroenterology. Currently serving as the Executive Medical Director and Global Development Lead at AbbVie, Kori has demonstrated a strong ability to lead clinical trials and strategic development for phase 3 assets. With a robust background in research, including a PhD focused on immunologic mechanisms, Kori has contributed significantly to the understanding of inflammatory bowel disease. Kori's career trajectory reflects a commitment to advancing medical science through innovative clinical practices and research. Beyond technical expertise, Kori is recognized for leadership in multidisciplinary teams, fostering collaboration across various departments. Kori's academic foundation from the University of Virginia and Arizona State University complements a practical approach to problem-solving in clinical settings. Passionate about improving patient outcomes, Kori remains at the forefront of emerging medical technologies and treatments.
Kori`s contact details
************@abbvie.com
Colleagues
Auditor
Legislative Aide
Graduate Student
Multiple Manufacturing & Supply Chain Roles
Financial Analyst Diagnostica R&D
Research Microbiologist
Finance Manager
Medical Office Receptionist
Coordinator, BMW Convertible Roof Design
Analyst